• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于单中心经验及文献综述的儿童1型黏多糖贮积症——神经放射学视角

Mucopolysaccharidosis Type 1 among Children-Neuroradiological Perspective Based on Single Centre Experience and Literature Review.

作者信息

Machnikowska-Sokołowska Magdalena, Myszczuk Aleksandra, Wieszała Emilia, Wieja-Błach Dominika, Jamroz Ewa, Paprocka Justyna

机构信息

Department of Diagnostic Imaging, Radiology and Nuclear Medicine, Faculty of Medical Sciences in Katowice, Medical University of Silesia in Katowice, 40-547 Katowice, Poland.

Diagnostic Imaging and Interventional Radiology Centre, The Independent Public Clinical Hospital No 6, 40-752 Katowice, Poland.

出版信息

Metabolites. 2023 Jan 31;13(2):209. doi: 10.3390/metabo13020209.

DOI:10.3390/metabo13020209
PMID:36837830
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9962124/
Abstract

Mucopolysaccharidosis 1 (MPS 1) is a group of rare lysosomal genetic disorders resulting from the accumulation of undegraded glycosaminoglycans (GAGs) leading to multiorgan damage. Neurological symptoms vary from mild to severe. Neuroimaging-mainly magnetic resonance (MRI)-plays a crucial role in disease diagnosis and monitoring. Early diagnosis is of the utmost importance due to the necessity of an early therapy implementation. New imaging tools like MR spectroscopy (MRS), semiquantitative MRI analysis and applying scoring systems help substantially in MPS 1 surveillance. The presented analysis of neuroimaging manifestations is based on 5 children with MPS 1 and a literature review. The vigilance of the radiologist based on knowledge of neuroradiological patterns is highlighted.

摘要

黏多糖贮积症1型(MPS 1)是一组罕见的溶酶体遗传性疾病,由未降解的糖胺聚糖(GAGs)蓄积所致,可导致多器官损害。神经症状轻重不一。神经影像学检查——主要是磁共振成像(MRI)——在疾病诊断和监测中起着关键作用。由于需要尽早实施治疗,早期诊断至关重要。诸如磁共振波谱(MRS)、半定量MRI分析和应用评分系统等新的成像工具对MPS 1的监测有很大帮助。本文对神经影像学表现的分析基于5例MPS 1患儿并结合文献综述。强调了放射科医生基于神经放射学模式知识的警惕性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c88/9962124/5096eee87531/metabolites-13-00209-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c88/9962124/055281ad850f/metabolites-13-00209-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c88/9962124/f46714e19178/metabolites-13-00209-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c88/9962124/815ce706df30/metabolites-13-00209-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c88/9962124/c5b4bb140a0a/metabolites-13-00209-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c88/9962124/67f227f2106a/metabolites-13-00209-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c88/9962124/276975b3893c/metabolites-13-00209-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c88/9962124/5096eee87531/metabolites-13-00209-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c88/9962124/055281ad850f/metabolites-13-00209-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c88/9962124/f46714e19178/metabolites-13-00209-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c88/9962124/815ce706df30/metabolites-13-00209-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c88/9962124/c5b4bb140a0a/metabolites-13-00209-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c88/9962124/67f227f2106a/metabolites-13-00209-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c88/9962124/276975b3893c/metabolites-13-00209-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c88/9962124/5096eee87531/metabolites-13-00209-sch001.jpg

相似文献

1
Mucopolysaccharidosis Type 1 among Children-Neuroradiological Perspective Based on Single Centre Experience and Literature Review.基于单中心经验及文献综述的儿童1型黏多糖贮积症——神经放射学视角
Metabolites. 2023 Jan 31;13(2):209. doi: 10.3390/metabo13020209.
2
[Mucopolysaccharidosis: clinical features, diagnosis and management].[黏多糖贮积症:临床特征、诊断与管理]
Rev Chil Pediatr. 2016 Jul-Aug;87(4):295-304. doi: 10.1016/j.rchipe.2015.10.004. Epub 2015 Nov 21.
3
Surgical management of neurological manifestations of mucopolysaccharidosis disorders.黏多糖贮积症神经表现的外科治疗。
Mol Genet Metab. 2017 Dec;122S:41-48. doi: 10.1016/j.ymgme.2017.09.011. Epub 2017 Sep 28.
4
Epilepsy in mucopolysaccharidosis disorders.黏多糖贮积症中的癫痫。
Mol Genet Metab. 2017 Dec;122S:55-61. doi: 10.1016/j.ymgme.2017.10.006. Epub 2017 Oct 16.
5
Altered interaction and distribution of glycosaminoglycans and growth factors in mucopolysaccharidosis type I bone disease.黏多糖贮积症I型骨病中糖胺聚糖与生长因子的相互作用及分布改变
Bone. 2016 Jul;88:92-100. doi: 10.1016/j.bone.2016.01.029. Epub 2016 Apr 19.
6
A basic understanding of mucopolysaccharidosis: Incidence, clinical features, diagnosis, and management.黏多糖贮积症的基本认识:发病率、临床特征、诊断与管理。
Intractable Rare Dis Res. 2020 Feb;9(1):1-9. doi: 10.5582/irdr.2020.01011.
7
Ocular features in mucopolysaccharidosis: diagnosis and treatment.黏多糖贮积症的眼部特征:诊断与治疗。
Ital J Pediatr. 2018 Nov 16;44(Suppl 2):125. doi: 10.1186/s13052-018-0559-9.
8
Imaging findings of mucopolysaccharidoses: a pictorial review.黏多糖贮积症的影像学表现:图像综述。
Insights Imaging. 2013 Aug;4(4):443-59. doi: 10.1007/s13244-013-0246-8. Epub 2013 May 5.
9
Early enzyme replacement therapy enables a successful hematopoietic stem cell transplantation in mucopolysaccharidosis type IH: Divergent clinical outcomes in two Japanese siblings.早期酶替代疗法可使Ⅰ型黏多糖贮积症成功进行造血干细胞移植:两名日本兄妹的不同临床结局
Brain Dev. 2019 Jun;41(6):546-550. doi: 10.1016/j.braindev.2019.01.008. Epub 2019 Feb 10.
10
Mucopolysaccharidosis type I.I型黏多糖贮积症
Pediatr Endocrinol Rev. 2014 Sep;12 Suppl 1:102-6.

引用本文的文献

1
Safety assessment of laronidase: real-world adverse event analysis based on the FDA adverse event reporting system (FAERS).拉罗尼酶的安全性评估:基于美国食品药品监督管理局不良事件报告系统(FAERS)的真实世界不良事件分析
Front Pharmacol. 2025 Aug 20;16:1623921. doi: 10.3389/fphar.2025.1623921. eCollection 2025.
2
Radiographic assessment of mucopolysaccharidoses: A pictorial review.黏多糖贮积症的影像学评估:图文综述
World J Clin Pediatr. 2025 Sep 9;14(3):102898. doi: 10.5409/wjcp.v14.i3.102898.
3
Challenges in Diagnosing and Managing Hurler Syndrome: A Case Report.

本文引用的文献

1
Newborn Screening in Japan-2021.日本的新生儿筛查 - 2021年
Int J Neonatal Screen. 2022 Jan 4;8(1):3. doi: 10.3390/ijns8010003.
2
Proposal of an Algorithm to Early Detect Attenuated Type I Mucopolysaccharidosis (MPS Ia) among Children with Growth Abnormalities.提出一种算法,以早期发现生长异常儿童中的 I 型黏多糖贮积症(MPS Ia)。
Medicina (Kaunas). 2022 Jan 8;58(1):97. doi: 10.3390/medicina58010097.
3
Quantitative brain MRI morphology in severe and attenuated forms of mucopolysaccharidosis type I.严重和轻度黏多糖贮积症Ⅰ型的定量脑 MRI 形态学研究。
黏多糖贮积症Ⅰ型诊断与管理中的挑战:一例报告
Cureus. 2024 Aug 17;16(8):e67056. doi: 10.7759/cureus.67056. eCollection 2024 Aug.
4
Mucopolysaccharidosis-Plus Syndrome: Is This a Type of Mucopolysaccharidosis or a Separate Kind of Metabolic Disease?黏多糖贮积症伴多发畸形综合征:这是一种黏多糖贮积症,还是一种独立的代谢疾病?
Int J Mol Sci. 2024 Sep 4;25(17):9570. doi: 10.3390/ijms25179570.
5
[Natural history of mucopolysaccharidosis type III in a series of Colombian patients].[哥伦比亚一系列黏多糖贮积症III型患者的自然病史]
Rev Neurol. 2024 Mar 16;78(6):171-177. doi: 10.33588/rn.7806.2023281.
Mol Genet Metab. 2022 Feb;135(2):122-132. doi: 10.1016/j.ymgme.2022.01.001. Epub 2022 Jan 7.
4
Hematopoietic Stem- and Progenitor-Cell Gene Therapy for Hurler Syndrome.用于黏多糖贮积症I型的造血干细胞和祖细胞基因疗法
N Engl J Med. 2021 Nov 18;385(21):1929-1940. doi: 10.1056/NEJMoa2106596.
5
Nationwide Newborn Screening Program for Mucopolysaccharidoses in Taiwan and an Update of the "Gold Standard" Criteria Required to Make a Confirmatory Diagnosis.台湾黏多糖贮积症全国新生儿筛查计划及确诊所需“金标准”标准的更新
Diagnostics (Basel). 2021 Aug 31;11(9):1583. doi: 10.3390/diagnostics11091583.
6
Evidence of Treatment Benefits in Patients with Mucopolysaccharidosis Type I-Hurler in Long-term Follow-up Using a New Magnetic Resonance Imaging Scoring System.采用新型磁共振成像评分系统对黏多糖贮积症 I 型Hurler 患者进行长期随访的治疗获益证据。
J Pediatr. 2022 Jan;240:297-301.e5. doi: 10.1016/j.jpeds.2021.09.020. Epub 2021 Sep 20.
7
MPS I: Early diagnosis, bone disease and treatment, where are we now?MPS I:早期诊断、骨骼疾病和治疗,我们现在在哪里?
J Inherit Metab Dis. 2021 Nov;44(6):1289-1310. doi: 10.1002/jimd.12431. Epub 2021 Sep 15.
8
Long term disease burden post-transplantation: three decades of observations in 25 Hurler patients successfully treated with hematopoietic stem cell transplantation (HSCT).移植后长期疾病负担:25 例成功接受造血干细胞移植(HSCT)治疗的粘多糖贮积症患者 30 年的观察结果。
Orphanet J Rare Dis. 2021 Jan 31;16(1):60. doi: 10.1186/s13023-020-01644-w.
9
Mucopolysaccharidosis Type I: A Review of the Natural History and Molecular Pathology.黏多糖贮积症 I 型:自然病史和分子病理学综述。
Cells. 2020 Aug 5;9(8):1838. doi: 10.3390/cells9081838.
10
Newborn screening of mucopolysaccharidoses: past, present, and future.新生儿黏多糖贮积症筛查:过去、现在和未来。
J Hum Genet. 2020 Jul;65(7):557-567. doi: 10.1038/s10038-020-0744-8. Epub 2020 Apr 10.